Additionally, A20 (TNFAIP3), a negative regulator of NF-κB, is overexpressed in IBD patient IECs and modulates RIPK1-mediated apoptosis; inhibition of RIPK1 protects A20-overexpressing mice from TNF-induced cell death [66,67]. Here, TNFAIP3 is linked to inflammatory bowel disease.